Updated February 19, 2017. There's no right way to study in college. Even students who have the same majors and take the same classes won't need to spend the same amount of time on coursework, because everyone has their own way of learning.
New Arthritis Drug Xeljanz Gets FDA Approval. Nov. 6, 2012 -- The FDA has approved Pfizer's Xeljanz (tofacitinib), a first-of-its-kind treatment for rheumatoid arthritis. Xeljanz is approved for use by patients not helped by methotrexate, the usual first treatment for RA. It's a pill taken twice a day. Xeljanz is a type of drug called a Janus kinase or JAK inhibitor. Blocking JAK mutes the inflammation responses responsible for RA.
RA has no cure, but medications can help relieve symptoms. These medications include anti-inflammatory drugs, corticosteroids, and drugs that suppress the immune system. Some of the most effective drug treatments are disease modifying anti-rheumatic drugs (DMARDs), which include TNF-alpha inhibitors. Tumor necrosis factor alpha, or TNF alpha, is a substance that occurs naturally in your body. In RA, the immune system cells that attack the joints create higher levels of TNF alpha. These high levels cause pain and swelling.